1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Transdermal Drug Delivery Systems Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Fentanyl 1.2.3 Nitroglycerin 1.2.4 Estradiol 1.2.5 Nicotine 1.2.6 Other 1.3 Market by Application 1.3.1 Global Transdermal Drug Delivery Systems Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 OTC 1.3.3 Rx 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Transdermal Drug Delivery Systems Market Perspective (2016-2027) 2.2 Transdermal Drug Delivery Systems Growth Trends by Regions 2.2.1 Transdermal Drug Delivery Systems Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Transdermal Drug Delivery Systems Historic Market Share by Regions (2016-2021) 2.2.3 Transdermal Drug Delivery Systems Forecasted Market Size by Regions (2022-2027) 2.3 Transdermal Drug Delivery Systems Industry Dynamic 2.3.1 Transdermal Drug Delivery Systems Market Trends 2.3.2 Transdermal Drug Delivery Systems Market Drivers 2.3.3 Transdermal Drug Delivery Systems Market Challenges 2.3.4 Transdermal Drug Delivery Systems Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Transdermal Drug Delivery Systems Players by Revenue 3.1.1 Global Top Transdermal Drug Delivery Systems Players by Revenue (2016-2021) 3.1.2 Global Transdermal Drug Delivery Systems Revenue Market Share by Players (2016-2021) 3.2 Global Transdermal Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Transdermal Drug Delivery Systems Revenue 3.4 Global Transdermal Drug Delivery Systems Market Concentration Ratio 3.4.1 Global Transdermal Drug Delivery Systems Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Transdermal Drug Delivery Systems Revenue in 2020 3.5 Transdermal Drug Delivery Systems Key Players Head office and Area Served 3.6 Key Players Transdermal Drug Delivery Systems Product Solution and Service 3.7 Date of Enter into Transdermal Drug Delivery Systems Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Transdermal Drug Delivery Systems Breakdown Data by Type 4.1 Global Transdermal Drug Delivery Systems Historic Market Size by Type (2016-2021) 4.2 Global Transdermal Drug Delivery Systems Forecasted Market Size by Type (2022-2027) 5 Transdermal Drug Delivery Systems Breakdown Data by Application 5.1 Global Transdermal Drug Delivery Systems Historic Market Size by Application (2016-2021) 5.2 Global Transdermal Drug Delivery Systems Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Transdermal Drug Delivery Systems Market Size (2016-2027) 6.2 North America Transdermal Drug Delivery Systems Market Size by Type 6.2.1 North America Transdermal Drug Delivery Systems Market Size by Type (2016-2021) 6.2.2 North America Transdermal Drug Delivery Systems Market Size by Type (2022-2027) 6.2.3 North America Transdermal Drug Delivery Systems Market Size by Type (2016-2027) 6.3 North America Transdermal Drug Delivery Systems Market Size by Application 6.3.1 North America Transdermal Drug Delivery Systems Market Size by Application (2016-2021) 6.3.2 North America Transdermal Drug Delivery Systems Market Size by Application (2022-2027) 6.3.3 North America Transdermal Drug Delivery Systems Market Size by Application (2016-2027) 6.4 North America Transdermal Drug Delivery Systems Market Size by Country 6.4.1 North America Transdermal Drug Delivery Systems Market Size by Country (2016-2021) 6.4.2 North America Transdermal Drug Delivery Systems Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Transdermal Drug Delivery Systems Market Size (2016-2027) 7.2 Europe Transdermal Drug Delivery Systems Market Size by Type 7.2.1 Europe Transdermal Drug Delivery Systems Market Size by Type (2016-2021) 7.2.2 Europe Transdermal Drug Delivery Systems Market Size by Type (2022-2027) 7.2.3 Europe Transdermal Drug Delivery Systems Market Size by Type (2016-2027) 7.3 Europe Transdermal Drug Delivery Systems Market Size by Application 7.3.1 Europe Transdermal Drug Delivery Systems Market Size by Application (2016-2021) 7.3.2 Europe Transdermal Drug Delivery Systems Market Size by Application (2022-2027) 7.3.3 Europe Transdermal Drug Delivery Systems Market Size by Application (2016-2027) 7.4 Europe Transdermal Drug Delivery Systems Market Size by Country 7.4.1 Europe Transdermal Drug Delivery Systems Market Size by Country (2016-2021) 7.4.2 Europe Transdermal Drug Delivery Systems Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Transdermal Drug Delivery Systems Market Size (2016-2027) 8.2 Asia-Pacific Transdermal Drug Delivery Systems Market Size by Type 8.2.1 Asia-Pacific Transdermal Drug Delivery Systems Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Transdermal Drug Delivery Systems Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Transdermal Drug Delivery Systems Market Size by Type (2016-2027) 8.3 Asia-Pacific Transdermal Drug Delivery Systems Market Size by Application 8.3.1 Asia-Pacific Transdermal Drug Delivery Systems Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Transdermal Drug Delivery Systems Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Transdermal Drug Delivery Systems Market Size by Application (2016-2027) 8.4 Asia-Pacific Transdermal Drug Delivery Systems Market Size by Region 8.4.1 Asia-Pacific Transdermal Drug Delivery Systems Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Transdermal Drug Delivery Systems Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Transdermal Drug Delivery Systems Market Size (2016-2027) 9.2 Latin America Transdermal Drug Delivery Systems Market Size by Type 9.2.1 Latin America Transdermal Drug Delivery Systems Market Size by Type (2016-2021) 9.2.2 Latin America Transdermal Drug Delivery Systems Market Size by Type (2022-2027) 9.2.3 Latin America Transdermal Drug Delivery Systems Market Size by Type (2016-2027) 9.3 Latin America Transdermal Drug Delivery Systems Market Size by Application 9.3.1 Latin America Transdermal Drug Delivery Systems Market Size by Application (2016-2021) 9.3.2 Latin America Transdermal Drug Delivery Systems Market Size by Application (2022-2027) 9.3.3 Latin America Transdermal Drug Delivery Systems Market Size by Application (2016-2027) 9.4 Latin America Transdermal Drug Delivery Systems Market Size by Country 9.4.1 Latin America Transdermal Drug Delivery Systems Market Size by Country (2016-2021) 9.4.2 Latin America Transdermal Drug Delivery Systems Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Transdermal Drug Delivery Systems Market Size (2016-2027) 10.2 Middle East & Africa Transdermal Drug Delivery Systems Market Size by Type 10.2.1 Middle East & Africa Transdermal Drug Delivery Systems Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Transdermal Drug Delivery Systems Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Transdermal Drug Delivery Systems Market Size by Type (2016-2027) 10.3 Middle East & Africa Transdermal Drug Delivery Systems Market Size by Application 10.3.1 Middle East & Africa Transdermal Drug Delivery Systems Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Transdermal Drug Delivery Systems Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Transdermal Drug Delivery Systems Market Size by Application (2016-2027) 10.4 Middle East & Africa Transdermal Drug Delivery Systems Market Size by Country 10.4.1 Middle East & Africa Transdermal Drug Delivery Systems Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Transdermal Drug Delivery Systems Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Hisamitsu 11.1.1 Hisamitsu Company Details 11.1.2 Hisamitsu Business Overview 11.1.3 Hisamitsu Transdermal Drug Delivery Systems Introduction 11.1.4 Hisamitsu Revenue in Transdermal Drug Delivery Systems Business (2016-2021) 11.1.5 Hisamitsu Recent Development 11.2 Mylan 11.2.1 Mylan Company Details 11.2.2 Mylan Business Overview 11.2.3 Mylan Transdermal Drug Delivery Systems Introduction 11.2.4 Mylan Revenue in Transdermal Drug Delivery Systems Business (2016-2021) 11.2.5 Mylan Recent Development 11.3 GSK 11.3.1 GSK Company Details 11.3.2 GSK Business Overview 11.3.3 GSK Transdermal Drug Delivery Systems Introduction 11.3.4 GSK Revenue in Transdermal Drug Delivery Systems Business (2016-2021) 11.3.5 GSK Recent Development 11.4 Novartis 11.4.1 Novartis Company Details 11.4.2 Novartis Business Overview 11.4.3 Novartis Transdermal Drug Delivery Systems Introduction 11.4.4 Novartis Revenue in Transdermal Drug Delivery Systems Business (2016-2021) 11.4.5 Novartis Recent Development 11.5 Teve(Actavis) 11.5.1 Teve(Actavis) Company Details 11.5.2 Teve(Actavis) Business Overview 11.5.3 Teve(Actavis) Transdermal Drug Delivery Systems Introduction 11.5.4 Teve(Actavis) Revenue in Transdermal Drug Delivery Systems Business (2016-2021) 11.5.5 Teve(Actavis) Recent Development 11.6 Johnson & Johnson 11.6.1 Johnson & Johnson Company Details 11.6.2 Johnson & Johnson Business Overview 11.6.3 Johnson & Johnson Transdermal Drug Delivery Systems Introduction 11.6.4 Johnson & Johnson Revenue in Transdermal Drug Delivery Systems Business (2016-2021) 11.6.5 Johnson & Johnson Recent Development 11.7 UCB 11.7.1 UCB Company Details 11.7.2 UCB Business Overview 11.7.3 UCB Transdermal Drug Delivery Systems Introduction 11.7.4 UCB Revenue in Transdermal Drug Delivery Systems Business (2016-2021) 11.7.5 UCB Recent Development 11.8 Teikoku Seiyaku 11.8.1 Teikoku Seiyaku Company Details 11.8.2 Teikoku Seiyaku Business Overview 11.8.3 Teikoku Seiyaku Transdermal Drug Delivery Systems Introduction 11.8.4 Teikoku Seiyaku Revenue in Transdermal Drug Delivery Systems Business (2016-2021) 11.8.5 Teikoku Seiyaku Recent Development 11.9 Bayer 11.9.1 Bayer Company Details 11.9.2 Bayer Business Overview 11.9.3 Bayer Transdermal Drug Delivery Systems Introduction 11.9.4 Bayer Revenue in Transdermal Drug Delivery Systems Business (2016-2021) 11.9.5 Bayer Recent Development 11.10 Lingrui 11.10.1 Lingrui Company Details 11.10.2 Lingrui Business Overview 11.10.3 Lingrui Transdermal Drug Delivery Systems Introduction 11.10.4 Lingrui Revenue in Transdermal Drug Delivery Systems Business (2016-2021) 11.10.5 Lingrui Recent Development 11.11 Sanofi 11.11.1 Sanofi Company Details 11.11.2 Sanofi Business Overview 11.11.3 Sanofi Transdermal Drug Delivery Systems Introduction 11.11.4 Sanofi Revenue in Transdermal Drug Delivery Systems Business (2016-2021) 11.11.5 Sanofi Recent Development 11.12 Qizheng 11.12.1 Qizheng Company Details 11.12.2 Qizheng Business Overview 11.12.3 Qizheng Transdermal Drug Delivery Systems Introduction 11.12.4 Qizheng Revenue in Transdermal Drug Delivery Systems Business (2016-2021) 11.12.5 Qizheng Recent Development 11.13 Endo 11.13.1 Endo Company Details 11.13.2 Endo Business Overview 11.13.3 Endo Transdermal Drug Delivery Systems Introduction 11.13.4 Endo Revenue in Transdermal Drug Delivery Systems Business (2016-2021) 11.13.5 Endo Recent Development 11.14 Huarun 999 11.14.1 Huarun 999 Company Details 11.14.2 Huarun 999 Business Overview 11.14.3 Huarun 999 Transdermal Drug Delivery Systems Introduction 11.14.4 Huarun 999 Revenue in Transdermal Drug Delivery Systems Business (2016-2021) 11.14.5 Huarun 999 Recent Development 11.15 Haw Par 11.15.1 Haw Par Company Details 11.15.2 Haw Par Business Overview 11.15.3 Haw Par Transdermal Drug Delivery Systems Introduction 11.15.4 Haw Par Revenue in Transdermal Drug Delivery Systems Business (2016-2021) 11.15.5 Haw Par Recent Development 11.16 Nichiban 11.16.1 Nichiban Company Details 11.16.2 Nichiban Business Overview 11.16.3 Nichiban Transdermal Drug Delivery Systems Introduction 11.16.4 Nichiban Revenue in Transdermal Drug Delivery Systems Business (2016-2021) 11.16.5 Nichiban Recent Development 11.17 Mentholatum Company 11.17.1 Mentholatum Company Company Details 11.17.2 Mentholatum Company Business Overview 11.17.3 Mentholatum Company Transdermal Drug Delivery Systems Introduction 11.17.4 Mentholatum Company Revenue in Transdermal Drug Delivery Systems Business (2016-2021) 11.17.5 Mentholatum Company Recent Development 11.18 Laboratoires Genevrier 11.18.1 Laboratoires Genevrier Company Details 11.18.2 Laboratoires Genevrier Business Overview 11.18.3 Laboratoires Genevrier Transdermal Drug Delivery Systems Introduction 11.18.4 Laboratoires Genevrier Revenue in Transdermal Drug Delivery Systems Business (2016-2021) 11.18.5 Laboratoires Genevrier Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Transdermal Drug Delivery Systems Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Fentanyl Table 3. Key Players of Nitroglycerin Table 4. Key Players of Estradiol Table 5. Key Players of Nicotine Table 6. Key Players of Other Table 7. Global Transdermal Drug Delivery Systems Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Transdermal Drug Delivery Systems Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 9. Global Transdermal Drug Delivery Systems Market Size by Regions (2016-2021) & (US$ Million) Table 10. Global Transdermal Drug Delivery Systems Market Share by Regions (2016-2021) Table 11. Global Transdermal Drug Delivery Systems Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 12. Global Transdermal Drug Delivery Systems Market Share by Regions (2022-2027) Table 13. Transdermal Drug Delivery Systems Market Trends Table 14. Transdermal Drug Delivery Systems Market Drivers Table 15. Transdermal Drug Delivery Systems Market Challenges Table 16. Transdermal Drug Delivery Systems Market Restraints Table 17. Global Transdermal Drug Delivery Systems Revenue by Players (2016-2021) & (US$ Million) Table 18. Global Transdermal Drug Delivery Systems Market Share by Players (2016-2021) Table 19. Global Top Transdermal Drug Delivery Systems Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transdermal Drug Delivery Systems as of 2020) Table 20. Ranking of Global Top Transdermal Drug Delivery Systems Companies by Revenue (US$ Million) in 2020 Table 21. Global 5 Largest Players Market Share by Transdermal Drug Delivery Systems Revenue (CR5 and HHI) & (2016-2021) Table 22. Key Players Headquarters and Area Served Table 23. Key Players Transdermal Drug Delivery Systems Product Solution and Service Table 24. Date of Enter into Transdermal Drug Delivery Systems Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Transdermal Drug Delivery Systems Market Size by Type (2016-2021) (US$ Million) Table 27. Global Transdermal Drug Delivery Systems Revenue Market Share by Type (2016-2021) Table 28. Global Transdermal Drug Delivery Systems Forecasted Market Size by Type (2022-2027) (US$ Million) Table 29. Global Transdermal Drug Delivery Systems Revenue Market Share by Type (2022-2027) & (US$ Million) Table 30. Global Transdermal Drug Delivery Systems Market Size Share by Application (2016-2021) & (US$ Million) Table 31. Global Transdermal Drug Delivery Systems Revenue Market Share by Application (2016-2021) Table 32. Global Transdermal Drug Delivery Systems Forecasted Market Size by Application (2022-2027) (US$ Million) Table 33. Global Transdermal Drug Delivery Systems Revenue Market Share by Application (2022-2027) & (US$ Million) Table 34. North America Transdermal Drug Delivery Systems Market Size by Type (2016-2021) (US$ Million) Table 35. North America Transdermal Drug Delivery Systems Market Size by Type (2022-2027) & (US$ Million) Table 36. North America Transdermal Drug Delivery Systems Market Size by Application (2016-2021) (US$ Million) Table 37. North America Transdermal Drug Delivery Systems Market Size by Application (2022-2027) & (US$ Million) Table 38. North America Transdermal Drug Delivery Systems Market Size by Country (2016-2021) & (US$ Million) Table 39. North America Transdermal Drug Delivery Systems Market Size by Country (2022-2027) & (US$ Million) Table 40. Europe Transdermal Drug Delivery Systems Market Size by Type (2016-2021) (US$ Million) Table 41. Europe Transdermal Drug Delivery Systems Market Size by Type (2022-2027) & (US$ Million) Table 42. Europe Transdermal Drug Delivery Systems Market Size by Application (2016-2021) (US$ Million) Table 43. Europe Transdermal Drug Delivery Systems Market Size by Application (2022-2027) & (US$ Million) Table 44. Europe Transdermal Drug Delivery Systems Market Size by Country (2016-2021) & (US$ Million) Table 45. Europe Transdermal Drug Delivery Systems Market Size by Country (2022-2027) & (US$ Million) Table 46. Asia-Pacific Transdermal Drug Delivery Systems Market Size by Type (2016-2021) (US$ Million) Table 47. Asia-Pacific Transdermal Drug Delivery Systems Market Size by Type (2022-2027) & (US$ Million) Table 48. Asia-Pacific Transdermal Drug Delivery Systems Market Size by Application (2016-2021) (US$ Million) Table 49. Asia-Pacific Transdermal Drug Delivery Systems Market Size by Application (2022-2027) & (US$ Million) Table 50. Asia-Pacific Transdermal Drug Delivery Systems Market Size by Region (2016-2021) & (US$ Million) Table 51. Asia-Pacific Transdermal Drug Delivery Systems Market Size by Region (2022-2027) & (US$ Million) Table 52. Latin America Transdermal Drug Delivery Systems Market Size by Type (2016-2021) (US$ Million) Table 53. Latin America Transdermal Drug Delivery Systems Market Size by Type (2022-2027) & (US$ Million) Table 54. Latin America Transdermal Drug Delivery Systems Market Size by Application (2016-2021) (US$ Million) Table 55. Latin America Transdermal Drug Delivery Systems Market Size by Application (2022-2027) & (US$ Million) Table 56. Latin America Transdermal Drug Delivery Systems Market Size by Country (2016-2021) & (US$ Million) Table 57. Latin America Transdermal Drug Delivery Systems Market Size by Country (2022-2027) & (US$ Million) Table 58. Middle East & Africa Transdermal Drug Delivery Systems Market Size by Type (2016-2021) (US$ Million) Table 59. Middle East & Africa Transdermal Drug Delivery Systems Market Size by Type (2022-2027) & (US$ Million) Table 60. Middle East & Africa Transdermal Drug Delivery Systems Market Size by Application (2016-2021) (US$ Million) Table 61. Middle East & Africa Transdermal Drug Delivery Systems Market Size by Application (2022-2027) & (US$ Million) Table 62. Middle East & Africa Transdermal Drug Delivery Systems Market Size by Country (2016-2021) & (US$ Million) Table 63. Middle East & Africa Transdermal Drug Delivery Systems Market Size by Country (2022-2027) & (US$ Million) Table 64. Hisamitsu Company Details Table 65. Hisamitsu Business Overview Table 66. Hisamitsu Transdermal Drug Delivery Systems Product Table 67. Hisamitsu Revenue in Transdermal Drug Delivery Systems Business (2016-2021) & (US$ Million) Table 68. Hisamitsu Recent Development Table 69. Mylan Company Details Table 70. Mylan Business Overview Table 71. Mylan Transdermal Drug Delivery Systems Product Table 72. Mylan Revenue in Transdermal Drug Delivery Systems Business (2016-2021) & (US$ Million) Table 73. Mylan Recent Development Table 74. GSK Company Details Table 75. GSK Business Overview Table 76. GSK Transdermal Drug Delivery Systems Product Table 77. GSK Revenue in Transdermal Drug Delivery Systems Business (2016-2021) & (US$ Million) Table 78. GSK Recent Development Table 79. Novartis Company Details Table 80. Novartis Business Overview Table 81. Novartis Transdermal Drug Delivery Systems Product Table 82. Novartis Revenue in Transdermal Drug Delivery Systems Business (2016-2021) & (US$ Million) Table 83. Novartis Recent Development Table 84. Teve(Actavis) Company Details Table 85. Teve(Actavis) Business Overview Table 86. Teve(Actavis) Transdermal Drug Delivery Systems Product Table 87. Teve(Actavis) Revenue in Transdermal Drug Delivery Systems Business (2016-2021) & (US$ Million) Table 88. Teve(Actavis) Recent Development Table 89. Johnson & Johnson Company Details Table 90. Johnson & Johnson Business Overview Table 91. Johnson & Johnson Transdermal Drug Delivery Systems Product Table 92. Johnson & Johnson Revenue in Transdermal Drug Delivery Systems Business (2016-2021) & (US$ Million) Table 93. Johnson & Johnson Recent Development Table 94. UCB Company Details Table 95. UCB Business Overview Table 96. UCB Transdermal Drug Delivery Systems Product Table 97. UCB Revenue in Transdermal Drug Delivery Systems Business (2016-2021) & (US$ Million) Table 98. UCB Recent Development Table 99. Teikoku Seiyaku Company Details Table 100. Teikoku Seiyaku Business Overview Table 101. Teikoku Seiyaku Revenue in Transdermal Drug Delivery Systems Business (2016-2021) & (US$ Million) Table 102. Teikoku Seiyaku Recent Development Table 103. Bayer Company Details Table 104. Bayer Business Overview Table 105. Bayer Transdermal Drug Delivery Systems Product Table 106. Bayer Revenue in Transdermal Drug Delivery Systems Business (2016-2021) & (US$ Million) Table 107. Bayer Recent Development Table 108. Lingrui Company Details Table 109. Lingrui Business Overview Table 110. Lingrui Transdermal Drug Delivery Systems Product Table 111. Lingrui Revenue in Transdermal Drug Delivery Systems Business (2016-2021) & (US$ Million) Table 112. Lingrui Recent Development Table 113. Sanofi Company Details Table 114. Sanofi Business Overview Table 115. Sanofi Transdermal Drug Delivery Systems Product Table 116. Sanofi Revenue in Transdermal Drug Delivery Systems Business (2016-2021) & (US$ Million) Table 117. Sanofi Recent Development Table 118. Qizheng Company Details Table 119. Qizheng Business Overview Table 120. Qizheng Transdermal Drug Delivery Systems Product Table 121. Qizheng Revenue in Transdermal Drug Delivery Systems Business (2016-2021) & (US$ Million) Table 122. Qizheng Recent Development Table 123. Endo Company Details Table 124. Endo Business Overview Table 125. Endo Transdermal Drug Delivery Systems Product Table 126. Endo Revenue in Transdermal Drug Delivery Systems Business (2016-2021) & (US$ Million) Table 127. Endo Recent Development Table 128. Huarun 999 Company Details Table 129. Huarun 999 Business Overview Table 130. Huarun 999 Transdermal Drug Delivery Systems Product Table 131. Huarun 999 Revenue in Transdermal Drug Delivery Systems Business (2016-2021) & (US$ Million) Table 132. Huarun 999 Recent Development Table 133. Haw Par Company Details Table 134. Haw Par Business Overview Table 135. Haw Par Transdermal Drug Delivery Systems Product Table 136. Haw Par Revenue in Transdermal Drug Delivery Systems Business (2016-2021) & (US$ Million) Table 137. Haw Par Recent Development Table 138. Nichiban Company Details Table 139. Nichiban Business Overview Table 140. Nichiban Transdermal Drug Delivery Systems Product Table 141. Nichiban Revenue in Transdermal Drug Delivery Systems Business (2016-2021) & (US$ Million) Table 142. Nichiban Recent Development Table 143. Mentholatum Company Company Details Table 144. Mentholatum Company Business Overview Table 145. Mentholatum Company Transdermal Drug Delivery Systems Product Table 146. Mentholatum Company Revenue in Transdermal Drug Delivery Systems Business (2016-2021) & (US$ Million) Table 147. Mentholatum Company Recent Development Table 148. Laboratoires Genevrier Company Details Table 149. Laboratoires Genevrier Business Overview Table 150. Laboratoires Genevrier Transdermal Drug Delivery Systems Product Table 151. Laboratoires Genevrier Revenue in Transdermal Drug Delivery Systems Business (2016-2021) & (US$ Million) Table 152. Laboratoires Genevrier Recent Development Table 153. Research Programs/Design for This Report Table 154. Key Data Information from Secondary Sources Table 155. Key Data Information from Primary Sources List of Figures Figure 1. Global Transdermal Drug Delivery Systems Market Share by Type: 2020 VS 2027 Figure 2. Fentanyl Features Figure 3. Nitroglycerin Features Figure 4. Estradiol Features Figure 5. Nicotine Features Figure 6. Other Features Figure 7. Global Transdermal Drug Delivery Systems Market Share by Application: 2020 VS 2027 Figure 8. OTC Case Studies Figure 9. Rx Case Studies Figure 10. Transdermal Drug Delivery Systems Report Years Considered Figure 11. Global Transdermal Drug Delivery Systems Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 12. Global Transdermal Drug Delivery Systems Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Transdermal Drug Delivery Systems Market Share by Regions: 2020 VS 2027 Figure 14. Global Transdermal Drug Delivery Systems Market Share by Regions (2022-2027) Figure 15. Global Transdermal Drug Delivery Systems Market Share by Players in 2020 Figure 16. Global Top Transdermal Drug Delivery Systems Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transdermal Drug Delivery Systems as of 2020 Figure 17. The Top 10 and 5 Players Market Share by Transdermal Drug Delivery Systems Revenue in 2020 Figure 18. Global Transdermal Drug Delivery Systems Revenue Market Share by Type (2016-2021) Figure 19. Global Transdermal Drug Delivery Systems Revenue Market Share by Type (2022-2027) Figure 20. North America Transdermal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million) Figure 21. North America Transdermal Drug Delivery Systems Market Share by Type (2016-2027) Figure 22. North America Transdermal Drug Delivery Systems Market Share by Application (2016-2027) Figure 23. North America Transdermal Drug Delivery Systems Market Share by Country (2016-2027) Figure 24. United States Transdermal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Canada Transdermal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Transdermal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Transdermal Drug Delivery Systems Market Share by Type (2016-2027) Figure 28. Europe Transdermal Drug Delivery Systems Market Share by Application (2016-2027) Figure 29. Europe Transdermal Drug Delivery Systems Market Share by Country (2016-2027) Figure 30. Germany Transdermal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. France Transdermal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. U.K. Transdermal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Italy Transdermal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Russia Transdermal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Nordic Transdermal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Transdermal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Transdermal Drug Delivery Systems Market Share by Type (2016-2027) Figure 38. Asia-Pacific Transdermal Drug Delivery Systems Market Share by Application (2016-2027) Figure 39. Asia-Pacific Transdermal Drug Delivery Systems Market Share by Region (2016-2027) Figure 40. China Transdermal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Japan Transdermal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. South Korea Transdermal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Southeast Asia Transdermal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. India Transdermal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Australia Transdermal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Transdermal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Transdermal Drug Delivery Systems Market Share by Type (2016-2027) Figure 48. Latin America Transdermal Drug Delivery Systems Market Share by Application (2016-2027) Figure 49. Latin America Transdermal Drug Delivery Systems Market Share by Country (2016-2027) Figure 50. Mexico Transdermal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Brazil Transdermal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Transdermal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Transdermal Drug Delivery Systems Market Share by Type (2016-2027) Figure 54. Middle East & Africa Transdermal Drug Delivery Systems Market Share by Application (2016-2027) Figure 55. Middle East & Africa Transdermal Drug Delivery Systems Market Share by Country (2016-2027) Figure 56. Turkey Transdermal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Saudi Arabia Transdermal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. UAE Transdermal Drug Delivery Systems Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Hisamitsu Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2016-2021) Figure 60. Mylan Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2016-2021) Figure 61. GSK Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2016-2021) Figure 62. Novartis Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2016-2021) Figure 63. Teve(Actavis) Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2016-2021) Figure 64. Johnson & Johnson Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2016-2021) Figure 65. UCB Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2016-2021) Figure 66. Teikoku Seiyaku Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2016-2021) Figure 67. Bayer Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2016-2021) Figure 68. Lingrui Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2016-2021) Figure 69. Sanofi Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2016-2021) Figure 70. Qizheng Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2016-2021) Figure 71. Endo Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2016-2021) Figure 72. Huarun 999 Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2016-2021) Figure 73. Haw Par Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2016-2021) Figure 74. Nichiban Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2016-2021) Figure 75. Mentholatum Company Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2016-2021) Figure 76. Laboratoires Genevrier Revenue Growth Rate in Transdermal Drug Delivery Systems Business (2016-2021) Figure 77. Bottom-up and Top-down Approaches for This Report Figure 78. Data Triangulation Figure 79. Key Executives Interviewed

Hisamitsu Mylan GSK Novartis Teve(Actavis) Johnson & Johnson UCB Teikoku Seiyaku Bayer Lingrui Sanofi Qizheng Endo Huarun 999 Haw Par Nichiban Mentholatum Company Laboratoires Genevrier